Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. - Wikidata - awgldk - TriplyDB

Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy.

Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy.

http://www.wikidata.org/entity/Q36403275

about

Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies The NuRD architecture Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity Cell death, clearance and immunity in the skeletal muscle Prognostic factors of idiopathic inflammatory myopathies complicated with interstitial lung disease: protocol for a systematic review and meta-analysis Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.Paraneoplastic myositis secondary to poorly differentiated serous carcinoma of ovarian/tubal origin.Aberrant muscle antigen exposure in mice is sufficient to cause myositis in a Treg cell-deficient milieu Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus.Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation.Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan Paraneoplastic syndromes associated with lung cancer Dermatomyositis and type 1 interferons.Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies.Diffuse cutaneous mucinosis in dermatomyositis: a case report and review of the literature.Review: cancer-induced autoimmunity in the rheumatic diseases.Cancer risk in dermatomyositis: a meta-analysis of cohort studies.Effects of nitric oxide on notexin-induced muscle inflammatory responses.Expression of the dermatomyositis autoantigen transcription intermediary factor 1γ in regenerating muscle.Paraneoplastic dermatomyositis with carcinoma cervix: a rare clinical association.Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.Carcinoma of gall bladder presenting as dermatomyositis.Mechanical-stretch of C2C12 myoblasts inhibits expression of Toll-like receptor 3 (TLR3) and of autoantigens associated with inflammatory myopathies.Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study Myositis autoantibodies and clinical phenotypes.Myositis-specific autoantibodies: detection and clinical associations.The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damage The lung as a possible target for the immune reaction in myositis.Brief report: antisynthetase syndrome-associated myocarditis Autoantibodies to transcription intermediary factor 1 in dermatomyositis shed insight into the cancer-myositis connection The heterogeneity of juvenile myositis Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome.The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study Juvenile dermatomyositis: new insights and new treatment strategies.

P2860

Q21090635-57EE458D-E34F-4484-81E7-37F4A169AF9A Q24605267-4E3F918C-2695-4FEF-96E3-F501850DB818 Q26798209-3296C46D-2763-431E-9D04-6BB77042951E Q26865710-C9202BBA-8679-41D6-A9A9-3EDB164E0CB9 Q27024588-90FD158C-74D1-4374-B095-4D0D2195927C Q28386837-E1A432E3-3D9E-4662-A937-3B3DD7E0AB27 Q28395250-C44E5918-6155-4B1A-95FC-1118DD7E9675 Q30252086-6707B22C-0DB8-4A46-886C-D93B3F675DA0 Q33561544-FC295641-858A-48C1-AE69-358A531465B3 Q33661671-D8EE6A57-8158-4EF7-9C29-98FA309E21ED Q33697662-12359538-D6FA-4596-A506-F3068EE34A47 Q33923345-7ABBD110-C00B-4E5C-B8D5-D735DF11E740 Q33923471-A4067CFE-1035-4DED-8441-8ABBD781D2E4 Q34023610-FC3D4F96-22D6-409F-9B53-CA6D47D3D75D Q34090905-C5A30E4C-B7B4-456D-9AC1-8C18D14250E7 Q34528042-4B0339AE-128D-4FA7-94EE-DE7578927B36 Q34609997-DA30B8FC-CF7F-4188-AC64-84D4D42CF214 Q34666066-8C5C1ED1-E9E0-4960-9D9C-54878DEF91E7 Q34668158-1E34A593-5C47-410E-9DCB-78700EE4662B Q34785515-8545F8ED-0265-4B2F-9D45-2D51DFB658F7 Q34791339-D0E192E1-4988-4ED6-B7B4-B6C89962311A Q34798861-177B068A-1A8E-4571-A3B5-082E37BF6787 Q35009335-843D1797-65B2-4669-9FEE-A4C4212CD219 Q35024631-BD9D0761-362D-4452-978C-3F1E81FC2584 Q35041551-CBD94C73-E920-45FE-BF2A-3FD71F90311C Q35092898-55F432EE-AD55-4D04-8485-C81A2CC66A2E Q35198594-6AD84346-5C80-4B54-AFF2-9FD33F6DD417 Q35281962-50F78911-758A-48DF-87B1-5FEAE8CCD9EC Q35309808-3395CD3D-CFA4-4926-AB92-920A3335765E Q35464924-D5456A38-C384-4FB6-B239-CD5EFB32D279 Q35617570-C8B5A94F-64D9-406C-BF43-5A135DD8AA86 Q35618761-8DEA0966-C320-4887-B61E-D21059AEDC44 Q35706669-EF15650D-3FE9-4A42-85B6-ADC84414F02F Q35748264-A3B87268-94F2-4ADF-A37F-67D79A7AC092 Q35761863-E1415AC1-1BC6-4049-A86C-CA9EEDB92758 Q35909737-D0FFCED9-6A66-4E99-B79F-35E0A2B1AE56 Q36001863-E86803F0-B8B6-49E8-9EA6-2564994C6B2F Q36013885-49A9C7B4-AE5E-4E13-A278-19617AB27159 Q36020198-79B5BAC7-6FAC-425C-A58C-B86D43351ABE Q36059542-D8E40B1B-290F-4439-A018-1CD448D18532

P2860

Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy.

http://www.wikidata.org/entity/Q36403275

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Enhanced autoantigen expressio ...... opathic inflammatory myopathy.

@ast

Enhanced autoantigen expressio ...... opathic inflammatory myopathy.

@en

type

label

Enhanced autoantigen expressio ...... opathic inflammatory myopathy.

@ast

Enhanced autoantigen expressio ...... opathic inflammatory myopathy.

@en

prefLabel

Enhanced autoantigen expressio ...... opathic inflammatory myopathy.

@ast

Enhanced autoantigen expressio ...... opathic inflammatory myopathy.

@en

P1433

Q36403275-2DBE7B29-8D18-48BD-A109-95A06102F39E

P1476

Q36403275-A1E40D2A-479C-49AD-A95B-92FF03F1A603

P2093

Q36403275-0FB135BE-6F5A-42CB-B062-A6A702E1E80A

Q36403275-3261CB6B-7799-4CB6-8355-F62DD0993A10

Q36403275-4577C012-83A4-481A-8667-CA7CB94E9362

Q36403275-502C15CE-CBCB-46F0-91D7-A6A4AA8A0C9A

Q36403275-5EB4A201-ED13-48B0-87AA-F5CB7E211832

Q36403275-6223EBC1-AA76-42F6-90C7-6E45501BB3BC

Q36403275-CE0DD4AA-47F2-4F19-A9E4-5E1CC61C831E

P2860

Q36403275-017578EF-2BCF-41B2-9B14-AA957798EB06

Q36403275-035B769C-319A-4955-8DCD-218AD251BAE6

Q36403275-0640289D-C0CD-45CE-8CAC-A26EE11E31FF

Q36403275-0A6B659D-427B-413E-AED6-CB83A49C372D

Q36403275-0AC0A435-5A7A-45AA-A338-61E4002A43F2

Q36403275-0DE9DD03-FD78-43B6-8097-EF6AD85C3389

Q36403275-16027993-A58C-4D88-B918-BA85B7679C9D

Q36403275-17F5207C-C33B-4FBC-B520-32CC26EA3E1A

Q36403275-1C8FCC37-3856-4B5D-8D4B-706C355E687E

Q36403275-21854D1B-D486-4560-8432-FFF77A9BAE56

P304

Q36403275-AF5388F3-30BC-4818-8D29-C6EB99122D95

P31

Q36403275-FB37D2BB-FDCA-403C-B210-25BED1F33D3A

P356

Q36403275-27F0C0D7-2CCD-45E8-869D-62C49EF8566E

P407

Q36403275-9B4939F4-D92A-4F69-91DF-300EA8D7F0FC

P433

Q36403275-7FC702DB-1500-4C92-9C7A-20E13F60B282

P478

Q36403275-0A2278A2-EC49-458C-A179-362458650573

P50

Q36403275-5E1915C4-68B7-41BD-B114-FF33323DC69C

P577

Q36403275-760D508E-7FDE-4569-B750-E3D4CE86D543

P5875

Q36403275-2B09E60F-DE80-4F09-9111-3BDA5DEF2E66

P698

Q36403275-98C7A1B2-BC93-4EBC-9BE6-5B6F041AF37B

P921

Q36403275-EE2BA44E-73AA-4D05-A274-146CD2BC35B0

P932

Q36403275-7F824D24-C6B6-43EE-9B39-E2B7AB47BB8C

P356

P1433

Journal of Experimental Medicine

P1476

Enhanced autoantigen expressio ...... opathic inflammatory myopathy.

@en

P2093

Andrea Corse

http://www.w3.org/2001/XMLSchema#string

Antony Rosen

http://www.w3.org/2001/XMLSchema#string

Edward Gabrielson

http://www.w3.org/2001/XMLSchema#string

Kondi Wang

http://www.w3.org/2001/XMLSchema#string

Livia Casciola-Rosen

http://www.w3.org/2001/XMLSchema#string

Paul Plotz

http://www.w3.org/2001/XMLSchema#string

Stuart Levine

http://www.w3.org/2001/XMLSchema#string

P2860

HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal

The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies

Human neoplasms elicit multiple specific immune responses in the autologous host

Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study

Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression

Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX

Paraneoplastic neurological degenerations: keys to tumour immunity

Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis

Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome

P304

591-601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20041367

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

201

http://www.w3.org/2001/XMLSchema#string

P50

Kanneboyina Nagaraju

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8005886

http://www.w3.org/2001/XMLSchema#string

P698

15728237

http://www.w3.org/2001/XMLSchema#string

P921

P932

2213068

http://www.w3.org/2001/XMLSchema#string